Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06153446 · ClinicalTrials.gov registry record
Infection Consortium Study#1
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 810
- Enrollment target
NCT06153446 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 810 participants.
The verdict
NCT06153446 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 810 participants
- Enrollment target
Study Summary
In this study, the Sponsor wants to evaluate the performance and accuracy of the PJI Panel compared to the currently used multiple-criterion scoring systems for the diagnosis of PJI.
Interventions
- DIAGNOSTIC_TEST Synovasure® Comprehensive Infection Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 810 participants |
| Start Date | 2023-12-10 |
| Est. Completion | 2025-09-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06153446
The ClinicalTrials.gov registry entry for NCT06153446 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 810 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synovasure® Comprehensive Infection Panel is the first listed.
NCT06153446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06153446 about?
NCT06153446 is a clinical study titled "Infection Consortium Study#1". In this study, the Sponsor wants to evaluate the performance and accuracy of the PJI Panel compared to the currently used multiple-criterion scoring systems for the diagnosis of PJI.
What is the current status of trial NCT06153446?
This trial is currently completed. The enrollment target is 810 participants. The study started on 2023-12-10. Estimated completion is 2025-09-04.
What interventions are being tested in trial NCT06153446?
The interventions under investigation include: Synovasure® Comprehensive Infection Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06153446?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.